Clinical Trial Update: Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating surgery with or without docetaxel and leuprolide or goserelin for high-risk localized prostate cancer; status ACTIVE_NOT_RECRUITING wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Goserelin (Goserelin)
• Leuprolide (Leuprolide acetate)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-01-13